Cargando…

Association between neuropeptide Y gene polymorphism and antipsychotics effect

OBJECTIVE: The pathogenesis of schizophrenia is associated with neuropeptide Y (NPY) gene polymorphism to explore the relationship between rs16141, rs16145, and rs5573 polymorphisms in the NPY gene and antipsychotics response in the Chinese population. METHODS: The unrelated 228 Chinese Han patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qian, Wan, Yajie, Du, Xinzhe, Gao, Yao, Wang, Xiao, Wu, Kewen, Zheng, Xiaohu, Wang, Yu, Zhao, Cheng, Li, Li, Guo, Xianju, Li, Xinrong, Liu, Sha, Xu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633956/ https://www.ncbi.nlm.nih.gov/pubmed/36339882 http://dx.doi.org/10.3389/fpsyt.2022.1014952

Ejemplares similares

Effect of childhood maltreatment on cognitive function and its relationship with personality development and social coping style in major depression disorder patients: A latent class model and network analysis
por: Wang, Xiao, et al.
Publicado: (2023)

The emerging role of long non-coding RNAs in schizophrenia
por: Wu, Guangxian, et al.
Publicado: (2022)

The neuropeptide Y single-nucleotide polymorphism rs16147:T>C moderates the effect of alcohol dependence on depression in male Chinese Han population
por: Wei, Xiaojie, et al.
Publicado: (2022)

Association of Serotonin(2c) Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia
por: Li, Jiang, et al.
Publicado: (2019)

Circular RNA in Schizophrenia and Depression
por: Li, Zexuan, et al.
Publicado: (2020)

Association of MTHFR C677T Polymorphism With Antipsychotic-Induced Change of Weight and Metabolism Index
por: Su, Yi, et al.
Publicado: (2021)

Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases
por: Gao, Panyue, et al.
Publicado: (2021)

Efficacy and Safety of Traditional Chinese Herbal Medicine for Antipsychotic-Related Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Rao, Wen-Wang, et al.
Publicado: (2021)

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
por: Yu, Hua, et al.
Publicado: (2023)

Meta-Analysis on the Association of Neuropeptide Y rs16139 Variant With the Risk of Alcoholism
por: Chen, Biqing, et al.
Publicado: (2021)

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

Neuroanatomical Features That Predict Response to Electroconvulsive Therapy Combined With Antipsychotics in Schizophrenia: A Magnetic Resonance Imaging Study Using Radiomics Strategy
por: Xi, Yi-Bin, et al.
Publicado: (2020)

Antipsychotics-induced improvement of cool executive function in individuals living with schizophrenia
por: Si, Yajing, et al.
Publicado: (2023)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

The Emerging Role of Neural Cell-Derived Exosomes in Intercellular Communication in Health and Neurodegenerative Diseases
por: Huo, Luyao, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study
por: Zhou, Xia, et al.
Publicado: (2020)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls
por: Engelke, Rudolf, et al.
Publicado: (2022)

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy
por: Zhang, Xiaobin, et al.
Publicado: (2020)

The Pharmacodynamics of Antipsychotic Drugs in Women and Men
por: Seeman, Mary V.
Publicado: (2021)

Non-antipsychotic medicines and modified electroconvulsive therapy are risk factors for hospital-acquired pneumonia in schizophrenia patients
por: Yang, Yan, et al.
Publicado: (2023)

Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis
por: Wang, Yuxia, et al.
Publicado: (2023)

Antipsychotic-Related Hypothermia: Five New Cases
por: Zonnenberg, Cherryl, et al.
Publicado: (2019)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
por: Fluyau, Dimy, et al.
Publicado: (2019)

The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies
por: Yang, Chengmin, et al.
Publicado: (2021)

Hippocampal Shape and Volume Changes with Antipsychotics in Early Stage Psychotic Illness
por: Mamah, Daniel, et al.
Publicado: (2012)

Exploration of the relationship between hippocampus and immune system in schizophrenia based on immune infiltration analysis
por: Du, Yanhong, et al.
Publicado: (2022)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Can Antipsychotic Agents be Considered as Real Antimanic Treatments?
por: Bourin, Michel, et al.
Publicado: (2014)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Hypothermia due to Antipsychotic Medication: A Systematic Review
por: Zonnenberg, Cherryl, et al.
Publicado: (2017)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
por: Koricanac, Aleksandra, et al.
Publicado: (2022)

Case report on antipsychotic induced catatonia in an incarcerated patient
por: Nguyen, Han, et al.
Publicado: (2023)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Yin, Ping, et al.
Publicado: (2021)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes
por: Li, Zongchang, et al.
Publicado: (2018)

Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis
por: Brandt, Lasse, et al.
Publicado: (2020)

The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
por: Libowitz, Mark R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kgtvf5uuda39h5icsh6f791amk